Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 9:04 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
ADAR1 Capital Management, LLC | 6,994,246 9.990% |
6,994,246 (New Position) |
Filing History |
| 2025-02-14 5:35 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Armistice Capital, LLC | 3,529,006 4.990% |
2,770,121 (+365.03%) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Nantahala Capital Management, LLC | 5,298,624 7.540% |
5,298,624 (New Position) |
Filing History |
| 2025-02-14 4:08 pm Sale |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Point72 Asset Management, L.P. | 0 0.000% |
-625,000 (Position Closed) |
Filing History |
| 2025-02-14 3:45 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Fairmount Funds Management LLC | 7,018,575 9.900% |
398,264 (+6.02%) |
Filing History |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | Inhibikase Therapeutics, Inc. IKT |
Armistice Capital, LLC | 758,885 9.990% |
758,885 (New Position) |
Filing History |
| 2024-10-28 5:26 pm Purchase |
2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT |
SP IKT Holdings LLC | 5,840,000 8.690% |
5,840,000 (New Position) |
Filing History |
| 2024-10-28 4:00 pm Purchase |
2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT |
Soleus Private Equity Fund III L.P. | 7,228,908 9.990% |
7,228,908 (New Position) |
Filing History |
| 2024-10-25 5:50 pm Purchase |
2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT |
Sands Capital Life Sciences Pulse Fund II. L.P. | 10,950,000 16.300% |
10,950,000 (New Position) |
Filing History |
| 2024-10-22 4:15 pm Purchase |
2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT |
PERCEPTIVE ADVISORS LLC | 6,799,944 9.990% |
6,799,944 (New Position) |
Filing History |
| 2024-10-17 7:00 pm Purchase |
2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT |
Fairmount Funds Management LLC | 6,620,311 9.900% |
6,620,311 (New Position) |
Filing History |
| 2024-10-17 4:05 pm Purchase |
2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT |
Commodore Capital LP | 6,807,507 9.990% |
6,807,507 (New Position) |
Filing History |
| 2024-10-10 4:10 pm Purchase |
2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT |
Point72 Asset Management, L.P. | 625,000 8.400% |
625,000 (New Position) |
Filing History |
| 2023-02-24 12:27 pm Sale |
2023-02-22 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 223,500 4.780% |
-29,333 (-11.60%) |
Filing History |
| 2023-02-15 7:45 pm Purchase |
2022-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Werner Milton H. | 926,485 19.680% |
16,812 (+1.85%) |
Filing History |
| 2023-01-31 11:59 am Unchanged |
2023-01-25 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 252,833 4.120% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:15 pm Purchase |
2021-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Werner Milton H. | 909,673 21.700% |
2,736 (+0.30%) |
Filing History |
| 2022-01-11 12:04 pm Purchase |
2022-01-10 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 252,833 6.030% |
44,500 (+21.36%) |
Filing History |
| 2021-12-15 12:52 pm Sale |
2021-12-14 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 208,333 4.970% |
-35,786 (-14.66%) |
Filing History |
| 2021-06-21 12:01 pm Purchase |
2021-06-16 | 13D | Inhibikase Therapeutics, Inc. IKT |
FiveT Investment Management Ltd | 244,119 5.830% |
244,119 (New Position) |
Filing History |